Sequel Med Tech obtained an FDA clearance opening up its twiist automated insulin delivery system to adults with type 2 diabetes. Launched earlier this year for people with type 1 diabetes, the company estimates the agency’s green light adds about 5.5 million people in the U.S. who manage their condition with insulin. Available through pharmacies […]
MassDevice Diabetes Hub
MassDevice's Diabetes Hub is your resource for the latest news in diabetes technology. Stay informed about the innovations and business news shaping the diabetes device industry.
Check out our latest feature:
Here are more top diabetes features from MassDevice, Drug Delivery Business News and sibling publications (and scroll down to read the latest diabetes device news from MassDevice):
+ The 10 largest diabetes tech companies in the world in 2026
+ 6 diabetes tech companies you need to know
+ Diabetes Technology Innovations Special Report — 2026
+ MiniMed flexes with next-gen insulin pump
+ The biggest diabetes tech news out of ADA 2026
+ 12 things you need to know about the CGM market
+ Our first Medtech Market Intelligence Report takes a deep dive into the CGM space
Latest Diabetes News
MiniMed completes split from Medtronic
MiniMed (Nasdaq: MMED) is celebrating its first day as an independent diabetes tech company, with the full completion of its spinoff from the Medtronic mothership. This week Medtronic reported the final results of its exchange offer for MiniMed stock, where it divested all of its remaining equity stake in the company through the swapping of […]
Insulet’s Omnipod Discover data platform begins full US rollout
Insulet’s (NASDAQ: PODD) web-based diabetes data platform is making its way to the U.S., designed to offer Omnipod users a view into their glucose and insulin trends while providing clinicians a way to deliver personalized recommendations. Dubbed Omnipod Discover, the system made its debut in multiple international markets earlier this year. Ahead of its full […]
Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
Novo (NYSE: NVO) has tapped the Swedish drug-delivery developer Nanexa to develop long-acting injectable platforms for its peptide meds, with a global licensing deal worth €1.165 billion, or about $1.32 billion U.S. The deal will support up to five R&D programs targeting monthly and quarterly injections, as the drugmaker looks to extend the reach of […]
Abbott partners with Berry Street to add nutrition coaching to Lingo
Abbott (NYSE: ABT) is teaming up with Berry Street to offer dietitian support programs to Lingo users. Wearers of the over-the-counter continuous glucose monitor can now sign up for personalized nutrition coaching linked to their data trends, and schedule virtual one-on-one appointments with registered and insurance-covered dietitians. At the same time, Berry Street users will […]
Dexcom CFO to expand into COO role
Dexcom‘s (Nasdaq:DXCM) C-suite is seeing another of its members take on multiple roles. Its chief financial officer will now also serve as chief operating officer. Jereme Sylvain joined the diabetes tech company in 2018, and has been its CFO and executive VP since 2021. His new COO hat will add oversight of Dexcom’s global operations […]
Beta Bionics insulin patch pump scores FDA clearance
Beta Bionics (NASDAQ: BBNX) has claimed an FDA clearance for its first patch pump insulin delivery system, amid plans to roll out an updated diabetes dosing algorithm and the launch of a new CGM partnership with Senseonics. The three-day, wearable Mint carries a 200-unit insulin reservoir as well as a combination of reusable and disposable […]
Medtronic moves to divest final stake in MiniMed
Medtronic (NYSE: MDT) is entering the final stretch of its long-running plan to split from its diabetes technology business, with the launch of an exchange offer that will allow stockholders to swap their company shares for those of the independent MiniMed (Nasdaq: MMED). With its catalog of insulin pumps, continuous glucose monitors and other diabetes […]
MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance
MiniMed (Nasdaq: MMED) today reported Street-beating first-quarter revenue, upping its full-year sales guidance as it notched an early European regulatory win. The Northridge, California–based diabetes tech company, spun out of Medtronic earlier this year, announced a CE mark for its next-gen, app-controlled MiniMed Flex insulin pump — well ahead of the company’s calendar 2026 year-end target. […]
MiniMed Flex now integrated with Abbot’s Instinct sensor
MiniMed (Nasdaq: MMED) announced that the MiniMed Flex system is now commercially shipping in the U.S. with the Instinct sensor, made by Abbott. The MiniMed Flex system is MiniMed’s smallest and only app-controlled insulin pump. According to the company, Instinct is the world’s smallest sensor and offers up to 15 days of wear. Powered by SmartGuard technology, MiniMed Flex automatically adjusts insulin delivery, and the Meal Detection technology can […]
Senseonics sees activist investor take a major stake
Activist investor Sessa Capital has taken a sizeable stake in long-term, implantable CGM company Senseonics (NYSE: SENS), according to an SEC Schedule 13G filed today. The SEC filing lists Sessa directly owning 4,437,532 shares of Senseonics common stock, with warrants to buy another 8,000,000 shares of stock subject to a 9.9% blocker provision that prevents investors from […]
